June 27, 2022
1 min watch
Save
VIDEO: ASCO highlights COVID challenges in multiple myeloma
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Amrita Krishnan, MD, director of the Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope Cancer Center, discusses the progress in multiple myeloma highlighted at ASCO Annual Meeting.
Krishnan specifically discusses the positive moves made in bispecific antibodies, but extensively delves into the challenges posed by the continuing COVID-19 pandemic.
“These are challenging times for us and the impact COVID has made upon our patients,” Krishnan said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Krishnan reports leadership roles with Sutro Biopharma; research funding to her institution from Janssen; consultant/advisory roles with Bristol Myers Squibb, GlaxoSmithKline and Janssen; speakers bureau roles with Amgen, Bristol Myers Squibb, GlaxoSmithKline and Takeda; and stock ownership in Bristol Myers Squibb.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.